Effects of febuxostat on markers of endothelial dysfunction and renal progression in patients with chronic kidney disease

Hyperuricemia relates to chronic kidney disease (CKD) progression and impaired endothelial function. Febuxostat is potent and effective for decreasing serum uric acid levels. Information for the effect of febuxostat treatment on markers of endothelial dysfunction and renal injury among patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Nata, Naowanit, Ninwisut, Nanthawut, Inkong, Pitchamon, Supasyndh, Ouppatham, Satirapoj, Bancha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439119/
https://www.ncbi.nlm.nih.gov/pubmed/37596359
http://dx.doi.org/10.1038/s41598-023-40767-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439119/
https://www.ncbi.nlm.nih.gov/pubmed/37596359
http://dx.doi.org/10.1038/s41598-023-40767-5

Ejemplares similares